Havn Life Sciences

(OTC) HAVLF

Current Price$0.00

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year-100%

1 Month+0%

Havn Life Sciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$586.98K

Net Income (TTM)

-CA$18.44M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-465.75 (Low)

Dividend

$0.00

Beta (Volatility)

-465.75 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 2, 2024

Dividend

$0.00

Beta (Volatility)

-465.75 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 2, 2024

HAVLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Havn Life Sciences

Industry

Biotechnology

Sector

Health Care

CEO

Tim Moore, MBA

Website

www.havnlife.com

Headquarters

Port Moody, BC V6W 1J5, CA

HAVLF Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

-35%

Net Income Margin

-81%

Return on Equity

Return on Capital

-3%

Return on Assets

-6%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

25.65M

Volume

Avg. Volume

0.203

Financials (TTM)

Gross Profit

CA$89.69K

Operating Income

-CA$9.81M

EBITDA

-CA$7.50M

Operating Cash Flow

-CA$7.88M

Capital Expenditure

-CA$103.07K

Free Cash Flow

-CA$7.98M

Cash & ST Invst.

CA$1.06M

Total Debt

CA$389.35K

Havn Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

-CA$12.06K

-152.4%

Gross Profit

-CA$83.33K

-1522.7%

Gross Margin

6.91%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$691.54K

+68.4%

EBITDA

-CA$691.43K

+66.1%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

CA$13.99K

-98.3%

Total Debt

CA$26.23K

-93.6%

Accounts Receivable

CA$271.56K

-68.7%

Inventory

CA$1.05M

+27.8%

Long Term Debt

CA$26.23K

-90.5%

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-5.53%

N/A

Return on Invested Capital

-2.84%

N/A

Free Cash Flow

CA$289.12K

+119.8%

Operating Cash Flow

CA$289.12K

+120.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AXIMAXIM Biotechnologies, Inc.

AXIMAXIM Biotechnologies, Inc.$0.01+0.00%

ARUXFAcrux Limited

ARUXFAcrux Limited$0.02+0.00%

ZLDAFZelira Therapeutics Limited

ZLDAFZelira Therapeutics Limited$0.35+0.00%

REPCFRepliCel Life Sciences Inc.

REPCFRepliCel Life Sciences Inc.$0.00+0.00%

ADXSAyala Pharmaceuticals, Inc.

ADXSAyala Pharmaceuticals, Inc.$0.60+0.00%

PKTXProtoKinetix, Incorporated

PKTXProtoKinetix, Incorporated$0.01+0.00%

RGBPRegen BioPharma, Inc.

RGBPRegen BioPharma, Inc.$0.00+100.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About HAVLF

What is the current price of Havn Life Sciences?

Havn Life Sciences is trading at $0.00 per share.

What is the 52-week range for Havn Life Sciences?

Over the past 52 weeks, Havn Life Sciences has traded between $0.00 and $0.00.

How much debt does Havn Life Sciences have?

As of the most recent reporting period, Havn Life Sciences reported total debt of CA$304.65K.

How much cash does Havn Life Sciences have on hand?

Havn Life Sciences reported CA$825.99K in cash and cash equivalents in its most recent financial results.

What is Havn Life Sciences’s dividend yield?

Havn Life Sciences does not currently have a dividend yield.

Havn Life Sciences

Havn Life Sciences Financials at a Glance

HAVLF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Havn Life Sciences

HAVLF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Havn Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HAVLF

What is the current price of Havn Life Sciences?

What is the 52-week range for Havn Life Sciences?

How much debt does Havn Life Sciences have?

How much cash does Havn Life Sciences have on hand?

What is Havn Life Sciences’s dividend yield?

Premium Investing Services